Utilization of Healthcare Resources in Osteoarthritis: A Cost of Illness Analysis Based on Real-World Data in Italy

بواسطة Colombo, Giorgio Lorenzo, Heiman, Franca, Peduto, Ilaria
الحاوية / القاعدة Ther Clin Risk Manag (2021)

Cost-effectiveness analysis on the use of rFSH + rLH for the treatment of anovulation in hypogonadotropic hypogonadal women

بواسطة Papaleo, Enrico, Alviggi, Carlo, Colombo, Giorgio Lorenzo, Pisanelli, Claudio, Ripellino, Claudio, Longobardi, Salvatore, Canonico, Pier Luigi
منشور في 2014

Cost-Utility Analysis of Saxagliptin/Dapagliflozin Versus Gliclazide and Insulin Glargine: Economic Implications of the Outcomes of the CVD-Real Studies I and II

بواسطة Torre, Enrico, Bruno, Giacomo Matteo, Di Matteo, Sergio, Martinotti, Chiara, Valentino, Maria Chiara, Bottaro, Luigi Carlo, Colombo, Giorgio Lorenzo
الحاوية / القاعدة Health Serv Insights (2020)

Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review

بواسطة Colombo, Giorgio Lorenzo, Di Matteo, Sergio, Martinotti, Chiara, Oselin, Martina, Valentino, Maria Chiara, Bruno, Giacomo Matteo, Pitotti, Claudia, Menzella, Francesco
الحاوية / القاعدة Ther Adv Respir Dis (2019)

Omalizumab for Severe Allergic Asthma Treatment in Italy: A Cost-Effectiveness Analysis from PROXIMA Study

بواسطة Canonica, Giorgio Walter, Colombo, Giorgio Lorenzo, Rogliani, Paola, Santus, Pierachille, Pitotti, Claudia, Di Matteo, Sergio, Martinotti, Chiara, Bruno, Giacomo Matteo
الحاوية / القاعدة Risk Manag Healthc Policy (2020)

Patterns of treatment and costs of intermediate and advanced hepatocellular carcinoma management in four Italian centers

بواسطة Colombo, Giorgio Lorenzo, Cammà, Calogero, Attili, Adolfo Francesco, Ganga, Roberto, Gaeta, Giovanni Battista, Brancaccio, Giuseppina, Franzini, Jean Marie, Volpe, Marco, Turchetti, Giuseppe
الحاوية / القاعدة Ther Clin Risk Manag (2015)

Cost-minimization analysis of degludec/liraglutide versus glargine/aspart: economic implications of the DUAL VII study outcomes

بواسطة Torre, Enrico, Bruno, Giacomo Matteo, Di Matteo, Sergio, Martinotti, Chiara, Oselin, Martina, Valentino, Maria Chiara, Parodi, Alessio, Bottaro, Luigi Carlo, Colombo, Giorgio Lorenzo
الحاوية / القاعدة Clinicoecon Outcomes Res (2018)

Economic Impact of COVID-19 Lockdown on Italian NHS: Focus on Diabetes Mellitus

بواسطة Torre, Enrico, Colombo, Giorgio Lorenzo, Di Matteo, Sergio, Martinotti, Chiara, Valentino, Maria Chiara, Rebora, Alberto, Cecoli, Francesca, Monti, Eleonora, Galimberti, Marco, Di Bartolo, Paolo, Gaggioli, Germano, Bruno, Giacomo Matteo
الحاوية / القاعدة Clinicoecon Outcomes Res (2021)

Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry

بواسطة Canonica, Giorgio Walter, Colombo, Giorgio Lorenzo, Bruno, Giacomo Matteo, Di Matteo, Sergio, Martinotti, Chiara, Blasi, Francesco, Bucca, Caterina, Crimi, Nunzio, Paggiaro, Pierluigi, Pelaia, Girolamo, Passalaqua, Giovanni, Senna, Gianenrico, Heffler, Enrico
الحاوية / القاعدة World Allergy Organ J (2019)